מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
lidocaine hydrochloride monohydrate, Quantity: 20 mg/mL
Bridgewest Perth Pharma Pty Ltd
lidocaine (lignocaine) hydrochloride monohydrate
Injection, solution
Excipient Ingredients: sodium chloride; water for injections
Intravenous, Epidural, Infiltration
5mL x 5, 5mL x 50
Medicine Registered
(S4) Prescription Only Medicine
Lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.
Visual Identification: Clear colourless solution; Container Type: Ampoule; Container Material: LDPE; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius
Registered
1994-06-22
LIGNOCAINE INJECTION _lidocaine (lignocaine)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Lignocaine Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Lignocaine Injection against the benefits this medicine is expected to have for you. This medicine is likely to be used while you are at the clinic or in hospital. If possible, please read this leaflet carefully before this medicine is given to you. In some cases this leaflet may be given to you after the medicine has been used. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET You may need to read it again. WHAT LIGNOCAINE INJECTION IS USED FOR Lignocaine Injection belongs to two groups of medicines known as local anaesthetics and antiarrhythmic drugs. Local anaesthetics stop pain and feeling in the area around where it is injected; and antiarrhythmic drugs work by restoring irregular and/or rapid heart beats to normal. Lignocaine Injection may be used for the management of other conditions that are not mentioned above. Your doctor will be able to tell you about the specific condition for which you have been prescribed Lignocaine Injection. This medicine is available only with a doctor's prescription. BEFORE YOU ARE GIVEN LIGNOCAINE INJECTION _WHEN YOU MUST NOT BE GIVEN_ _IT_ DO NOT USE LIGNOCAINE INJECTION IF: • you have an allergy to lignocaine or any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include shortness of breath, wheezing or difficulty breathing, swelling of the face, lips, tongue or other parts of the body, rash, itching or hives on the skin. • you have an infection or swelling where the injection will be given • you have blood infections or disorders • you are in severe shock • you have low blood pressure • you have dis קרא את המסמך השלם
Version: pfpligni11220 Supersedes: pfpligni10320 Page 1 of 19 AUSTRALIAN PRODUCT INFORMATION – LIGNOCAINE INJECTION (LIDOCAINE (LIGNOCAINE) HYDROCHLORIDE MONOHYDRATE) 1. NAME OF THE MEDICINE lidocaine (lignocaine) hydrochloride monohydrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Lignocaine Injection contains 10 mg or 20 mg lidocaine (lignocaine) hydrochloride monohydrate. For the full list of excipients, see section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Solution for injection. Lignocaine Injection is a clear, colourless, sterile, isotonic, preservative-free solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lidocaine (lignocaine) is indicated for production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest. 4.2 DOSE AND METHOD OF ADMINISTRATION DOSAGE _AS A LOCAL ANAESTHETIC FOR INFILTRATION AND NERVE BLOCK: _ The dosage varies and depends upon the area to be anaesthetised, vascularity of the tissues, number of neuronal segments to be blocked, individual tolerance and the technique of anaesthesia. The lowest dose needed to provide effective anaesthesia should be administered. For specific techniques and procedures, refer to standard textbooks. It is recommended that the dose of lidocaine (lignocaine) at any one time should not exceed 3 mg/kg. However, the dose administered must be tailored to the individual patient and procedure, and the maximum doses here quoted should be used as a guide only. Version: pfpligni11220 Supersedes: pfpligni10320 Page 2 of 19 The normal recommended dose of lidocaine (lignocaine) for various anaesthetic procedures in an average, healthy 70 kg adult patient are as follows: Procedure Concentration (%) Volume (mL) Dose (mg) Infiltrat קרא את המסמך השלם